Growth • Innoviva
INVA
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
6,6%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
-7,5%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
-31,7%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
-24,1%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
-4,1%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
-6%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!